. Goh JXH, et al.Cancers (Basel). 2019 Jun 21;11(6):867. doi: 10.3390/cancers11060867.Cancers (Basel). 2019.PMID: 31234411
.
What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P.Petrini P.
.
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small cell lung cancer.
Schoenfeld AJ, Antonia SJ, Awad MM, Felip E, Gainor J, Gettinger SN, Hodi FS, Johnson ML, Leighl NB, Lovly CM, Mok T, Perol M, Reck M, Solomon B, Soria JC, Tan DSW, Peters S, Hellmann MD.
.